• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Stevens-Johnson syndrome-like erosive dermatitis possibly related to afatinib.

作者信息

Honda Yuki, Hattori Yukari, Katsura Satoshi, Terashima Tsuyoshi, Manabe Toshiaki, Otsuka Atsushi, Miyachi Yoshiki

机构信息

Division of Dermatology, Shiga Medical Center for Adults, Shiga.

Division of Pathology, Shiga Medical Center for Adults, Shiga.

出版信息

Eur J Dermatol. 2016 Aug 1;26(4):413-4. doi: 10.1684/ejd.2016.2807.

DOI:10.1684/ejd.2016.2807
PMID:27212422
Abstract
摘要

相似文献

1
Stevens-Johnson syndrome-like erosive dermatitis possibly related to afatinib.史蒂文斯－约翰逊综合征样糜烂性皮炎，可能与阿法替尼有关。
Eur J Dermatol. 2016 Aug 1;26(4):413-4. doi: 10.1684/ejd.2016.2807.
2
Severe purpuric xerotic dermatitis associated with gefitinib therapy.与吉非替尼治疗相关的严重紫癜性干性皮炎。
Arch Dermatol. 2008 Feb;144(2):269-70. doi: 10.1001/archdermatol.2007.53.
3
Exfoliative eruption secondary to gefitinib (ZD1839).吉非替尼（ZD1839）继发的剥脱性皮疹
Dermatology. 2007;215(3):266-8. doi: 10.1159/000106590.
4
Acneiform lesions secondary to ZD1839, an inhibitor of the epidermal growth factor receptor.由表皮生长因子受体抑制剂ZD1839引发的痤疮样皮损。
Clin Exp Dermatol. 2004 Mar;29(2):138-40. doi: 10.1111/j.1365-2230.2004.01466.x.
5
Erlotinib-associated dermatological toxicity.厄洛替尼相关的皮肤毒性。
QJM. 2013 Apr;106(4):363-4. doi: 10.1093/qjmed/hcs164. Epub 2012 Aug 26.
6
Severe cutaneous toxicity following treatment with gefitinib (ZD1839).吉非替尼（ZD1839）治疗后出现的严重皮肤毒性。
Br J Dermatol. 2005 Dec;153(6):1222-3. doi: 10.1111/j.1365-2133.2005.06885.x.
7
Papulopustular eruptions in a 32-year-old woman after lung cancer treatment.
Arch Dermatol. 2011 Jun;147(6):735-40. doi: 10.1001/archdermatol.2011.127-a.
8
Stevens-Johnson syndrome/toxic epidermal necrolysis overlap in a NSCLC patient treated with afatinib.一名接受阿法替尼治疗的非小细胞肺癌患者出现史蒂文斯-约翰逊综合征/中毒性表皮坏死松解症重叠征。
J Dtsch Dermatol Ges. 2018 Feb;16(2):199-201. doi: 10.1111/ddg.13412. Epub 2018 Jan 12.
9
Erlotinib-induced skin manifestations.厄洛替尼引起的皮肤表现。
J Dermatol. 2009 Dec;36(12):658-9. doi: 10.1111/j.1346-8138.2009.00727.x.
10
Gefitinib-induced acute generalized exanthematous pustulosis in two patients with advanced non-small-cell lung cancer.吉非替尼诱发两名晚期非小细胞肺癌患者发生急性泛发性脓疱性皮病。
Br J Dermatol. 2006 Nov;155(5):1101-2. doi: 10.1111/j.1365-2133.2006.07511.x.

引用本文的文献

1
Emerging Insights into Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Induced by Immune Checkpoint Inhibitor and Tumor-Targeted Therapy.免疫检查点抑制剂和肿瘤靶向治疗诱导的史蒂文斯-约翰逊综合征和中毒性表皮坏死松解症的新见解
J Inflamm Res. 2024 Apr 17;17:2337-2351. doi: 10.2147/JIR.S454673. eCollection 2024.
2
Skin microbial dysbiosis is a characteristic of systemic drug-related intertriginous and flexural exanthema-like lesions induced by EGFR inhibitor.皮肤微生物群失调是表皮生长因子受体（EGFR）抑制剂诱导的系统性药物相关的擦烂性和屈侧疹样病变的一个特征。
Heliyon. 2023 Nov 3;9(11):e21690. doi: 10.1016/j.heliyon.2023.e21690. eCollection 2023 Nov.
3
Evaluation of Delayed-Type Hypersensitivity to Antineoplastic Drugs-An Overview.
抗肿瘤药物迟发型超敏反应的评估——综述
Cancers (Basel). 2023 Feb 14;15(4):1208. doi: 10.3390/cancers15041208.
4
Toxic epidermal necrosis associated with afatinib: A case report and literature review.阿法替尼相关的中毒性表皮坏死松解症：一例报告及文献综述
Front Oncol. 2023 Jan 9;12:1010052. doi: 10.3389/fonc.2022.1010052. eCollection 2022.
5
The relationship between medication literacy and skin adverse reactions in non-small-cell lung cancer patients undergoing targeted EGFR-TKI therapy.接受靶向 EGFR-TKI 治疗的非小细胞肺癌患者的药物使用素养与皮肤不良反应之间的关系。
BMC Cancer. 2022 May 3;22(1):491. doi: 10.1186/s12885-022-09599-w.
6
Mechanism of Lethal Skin Toxicities Induced by Epidermal Growth Factor Receptor Inhibitors and Related Treatment Strategies.表皮生长因子受体抑制剂诱导致死性皮肤毒性的机制及相关治疗策略
Front Oncol. 2022 Feb 10;12:804212. doi: 10.3389/fonc.2022.804212. eCollection 2022.
7
Potentially life‑threatening severe cutaneous adverse reactions associated with tyrosine kinase inhibitors (Review).与酪氨酸激酶抑制剂相关的潜在危及生命的严重皮肤不良反应（综述）。
Oncol Rep. 2021 Mar;45(3):891-898. doi: 10.3892/or.2020.7911. Epub 2020 Dec 24.
8
Severe cutaneous adverse reactions induced by targeted anticancer therapies and immunotherapies.靶向抗癌疗法和免疫疗法引起的严重皮肤不良反应。
Cancer Manag Res. 2018 May 17;10:1259-1273. doi: 10.2147/CMAR.S163391. eCollection 2018.
9
Anticancer Drugs Induced Severe Adverse Cutaneous Drug Reactions: An Updated Review on the Risks Associated with Anticancer Targeted Therapy or Immunotherapies.抗癌药物引起的严重皮肤不良反应：抗癌靶向治疗或免疫治疗相关风险的最新综述。
J Immunol Res. 2018 Jan 17;2018:5376476. doi: 10.1155/2018/5376476. eCollection 2018.
10
Crizotinib-associated toxic epidermal necrolysis in an ALK-positive advanced NSCLC patient.克唑替尼相关的中毒性表皮坏死松解症在一名ALK阳性晚期非小细胞肺癌患者中发生。
Mol Clin Oncol. 2018 Mar;8(3):457-459. doi: 10.3892/mco.2018.1553. Epub 2018 Jan 11.